AGR2 and pancreatic neoplasm: In a biodistribution study using radiolabeled anti-AGR2 monoclonal antibody P3A5, an implanted murine Agr2+ pancreatic tumor was specifically labeled whereas the bladder, lung (and pancreas) were not (unpublished data of Drs. Laurent Dumartin and Tatjana Crnogorac-Jurcevic, Queen Mary University of London).